Lanova Medicines Limited

This early-stage clinical trial is testing a new drug called LM-2417, both alone and combined with other cancer treatments, in people with advanced solid tumors that have stopped responding to standard therapies. The main goals are to find the safest and most effective dose and t…

This early-stage study is testing a new drug called LM-168, both alone and combined with an existing immunotherapy (toripalimab), in people with advanced solid tumors that have stopped responding to standard treatments. The first phase aims to find safe dose levels, while the sec…

This study is testing whether a new drug called LM-24C5, when combined with other cancer treatments, can help control advanced solid tumors that have a specific marker called CEACAM5. It will involve about 130 adults with advanced cancer that has returned or isn't responding to s…

This is the first human study of an experimental drug called LM-24C5 for people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also look for early signs…

This is the first study in people testing a new drug called LM-350 for advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also check for early signs that the dru…